Allscripts Selects ID.me to Power Healthcare Provider Identity Verification and Authentication for Electronic Prescription of Controlled Substances (EPCS)
MCLEAN, VA. (PRWEB) FEBRUARY 26, 2019 — ID.me today announced that it will power identity proofing and multifactor authentication for healthcare providers using Allscripts’ platform to electronically prescribe controlled substances. Allscripts’ electronic health record platforms connects 2,500 hospitals and 300,000 physicians, together serving 16 million patients.
In an effort to mitigate the opioid crisis, state-level legislation requires providers in certain states to stop using paper pads in favor of electronic prescriptions which are more resistant to fraud. Federal law will require all providers to only use electronic prescriptions for controlled substances after January 1, 2021. To comply with this legislation, the Drug Enforcement Administration (DEA) requires NIST 800-63-3 compliant digital credentials for healthcare providers to electronically prescribe controlled substances (EPCS).
ID.me’s EPCS Identity Proofing verifies that the healthcare provider prescribing is who they say they are and validates healthcare provider credentials, including DEA and NPI identifiers. Starting in March 2019, Allscripts will integrate with ID.me to allow prescribers to verify their identity with ID.me as required by Drug Enforcement Administration (DEA) regulations. Registration is conducted via an online self-serve flow or virtually via video chat with ID.me call center representatives.
Blake Hall, CEO and Founder of ID.me, commented on the role of identity proofing in securing electronic prescription of controlled substances. “With secure digital identity, malicious actors will have a much more difficult time perpetrating opioid abuse,” Hall said. “Our solution conforms to rigorous federal requirements for prescribing controlled substances, yet we have taken great care to ensure the process is also accessible for providers so they can spend as much time as possible caring for patients.”
ID.me’s EPCS Identity Proofing is compliant with the new NIST 800-63-3 Identity Assurance Level (IAL) 2 and Authenticator Assurance Level (AAL) 2 standards. The Drug Enforcement Administration (DEA) mandates that healthcare providers must use credentialing software that meets these guidelines if they are to electronically prescribe certain drugs, like opioids.
Beyond EPCS, these standards are being recommended in the upcoming Trusted Exchange Framework and Common Agreement to be published by the U.S. Department of Health and Human Services (HHS), defining standards for interoperability between healthcare systems and identity guidelines for patient portals.
In August 2018, ID.me became the first Credential Service Provider to be recognized under Kantara’s new NIST 800-63 rev.3 Class of Approval, reinforcing ID.me’s leading place in the identity ecosphere. ID.me has credentialed hundreds of thousands of military veterans accessing their healthcare through VA.gov.
ID.me is simplifying how individuals securely prove and share their identity online. The company is building a digital identity network where users verify their identity once and never have to re-verify their identity again across any organization where ID.me is accepted — mimicking the role of their driver’s license in the physical world.
About ID.me
ID.me’s next-generation identity platform provides identity proofing, authentication, and group affiliation verification for organizations across sectors. ID.me’s technology enables healthcare organizations to verify the identity of patients for patient portals and of healthcare providers for the e-prescribing of controlled substances. Our technology meets the highest federal standards for online identity proofing and authentication and is approved as a NIST 800-63-3 IAL2 / AAL2 conformant Credential Service Provider by the Kantara Initiative.
ID.me is used by more than 10MM individuals and 300 partners, including healthcare organizations, federal and state government agencies, financial institutions, retailers, and nonprofits.
“Our solution conforms to rigorous federal requirements for prescribing controlled substances, yet we have taken great care to ensure the process is also accessible for providers so they can spend as much time as possible caring for patients.
